INVASIVE CANDIDIASIS
Clinical trials for INVASIVE CANDIDIASIS explained in plain language.
Never miss a new study
Get alerted when new INVASIVE CANDIDIASIS trials appear
Sign up with your email to follow new studies for INVASIVE CANDIDIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Biomarker strategy cuts unnecessary antifungal use in ICU without raising death risk
Disease control CompletedThis study looked at 192 critically ill patients who were given antifungal drugs for a suspected fungal infection. Researchers wanted to see if using special fungal biomarkers could allow doctors to safely stop the drugs earlier than usual. The goal was to reduce unnecessary medi…
Matched conditions: INVASIVE CANDIDIASIS
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New blood tests could speed up fungal infection diagnosis
Diagnosis CompletedThis study looked at whether combining several blood tests can detect serious fungal infections (candidemia) faster and more accurately than standard methods. Researchers tested 2 adult hospital patients with suspected fungal infections using a panel of biomarkers and DNA tests. …
Matched conditions: INVASIVE CANDIDIASIS
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Diagnosis
Last updated May 20, 2026 11:53 UTC
-
New drug shows promise in preventing deadly fungal infections after transplant
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin works better at keeping…
Matched conditions: INVASIVE CANDIDIASIS
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated May 26, 2026 11:59 UTC
-
ICU patients may need custom doses of common antifungal drug
Knowledge-focused CompletedThis study looked at how the antifungal drug micafungin behaves in critically ill ICU patients with invasive candidiasis, a serious fungal infection. Researchers measured drug levels in 60 patients to see if standard doses are enough or if personalized dosing is needed. The goal …
Matched conditions: INVASIVE CANDIDIASIS
Phase: PHASE4 • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated May 26, 2026 12:06 UTC